Andreas W.

Andreas W. is a seasoned biotech executive with extensive experience in biotechnology and pharmaceutical consulting. Since 2005, Andreas has held leadership roles at Breakthrough CMC, focusing on development, Tech Ops, and GXP Quality. As the Principal Consultant for Woppmann Consulting, LLC, Andreas advises US and European companies on strategic and operational support for biopharma, emphasizing expedited product development and global commercialization. Additional consulting roles include positions at AI Proteins, Lubris BioPharma, and Sabin Vaccine Institute, among others. Prior executive roles at Syntimmune and ARIAD Pharmaceuticals involved overseeing innovative oncology product development. Andreas holds advanced degrees in molecular biology and neurobiology from esteemed institutions, including the University of Southern California and the Max-Planck-Institute.